Deer VI & Co. LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 93 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.

Quarter-by-quarter ownership
Deer VI & Co. LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$2,235,000
+46.5%
675,2420.0%100.00%0.0%
Q2 2018$1,526,000
-22.1%
675,2420.0%100.00%0.0%
Q1 2018$1,958,000
+3.9%
675,2420.0%100.00%0.0%
Q4 2017$1,884,000
-23.6%
675,2420.0%100.00%0.0%
Q3 2017$2,465,000
+64.4%
675,2420.0%100.00%0.0%
Q2 2017$1,499,000
+276.6%
675,2420.0%100.00%0.0%
Q1 2017$398,000
+9.0%
675,2420.0%100.00%
+36263.6%
Q4 2016$365,000
-39.3%
675,2420.0%0.28%
-56.8%
Q3 2016$601,000
-7.3%
675,2420.0%0.64%
-13.2%
Q2 2016$648,000
+4.3%
675,2420.0%0.73%
+20.3%
Q1 2016$621,000
-27.0%
675,2420.0%0.61%
-36.0%
Q4 2015$851,000
+4.2%
675,2420.0%0.95%
-21.9%
Q3 2015$817,000
-30.5%
675,2420.0%1.22%
+17.9%
Q2 2015$1,175,000
+20.0%
675,2420.0%1.04%
+3.7%
Q1 2015$979,000
+72.7%
675,2420.0%1.00%
+121.5%
Q4 2014$567,000
-24.4%
675,2420.0%0.45%
-2.6%
Q3 2014$750,000
-39.3%
675,2420.0%0.46%
-32.4%
Q2 2014$1,236,000
+22.0%
675,2420.0%0.68%
+57.1%
Q1 2014$1,013,000
-18.0%
675,2420.0%0.44%
+7.1%
Q4 2013$1,236,000
-11.1%
675,2420.0%0.41%
-18.3%
Q3 2013$1,391,000
-17.6%
675,2420.0%0.50%
-26.9%
Q2 2013$1,688,000675,2420.68%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 25,243,865$16,913,0001.18%
SABBY MANAGEMENT, LLC 281,112$189,0000.24%
New Leaf Venture Partners, L.L.C. 402,118$271,0000.07%
WealthTrust Axiom LLC 134,585$90,0000.03%
EXCALIBUR MANAGEMENT CORP 51,000$34,0000.03%
Caption Management, LLC 748,200$503,0000.02%
Anson Funds Management LP 98,986$66,0000.02%
GSA CAPITAL PARTNERS LLP 210,474$142,0000.02%
Evercore Wealth Management, LLC 418,414$282,0000.01%
Gemmer Asset Management LLC 1,939$31,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders